Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients

BACKGROUND: Immunotherapy using high dose interleukin-2 (HD IL2) in patients with renal cell carcinoma (RCC) and melanoma is associated with severe toxicities. The association between annual hospital volume of HD IL2 and inpatient mortality is not well studied. In this study we aim to quantify the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Kathan, Appleman, Leonard, Wang, Hong, Tarhini, Ahmad A., Parikh, Rahul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723120/
https://www.ncbi.nlm.nih.gov/pubmed/26799322
http://dx.doi.org/10.1371/journal.pone.0147153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723120/
https://www.ncbi.nlm.nih.gov/pubmed/26799322
http://dx.doi.org/10.1371/journal.pone.0147153

Ejemplares similares